| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |